ENSYSCE BIOSCIENCES, INC. Adjustments to Additional Paid in Capital, Warrant Issued
ENSYSCE BIOSCIENCES, INC. (ENSC) reported Adjustments to Additional Paid in Capital, Warrant Issued of $1.07 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-10.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2025-03-10
- ENSYSCE BIOSCIENCES, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2021-12-31 was $0.00.
- ENSYSCE BIOSCIENCES, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2021-09-30 was $11.57M.
- ENSYSCE BIOSCIENCES, INC. adjustments to additional paid in capital, warrant issued for fiscal 2023 was $1.07M.
- ENSYSCE BIOSCIENCES, INC. adjustments to additional paid in capital, warrant issued for fiscal 2021 was $11.57M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2023-12-31 | $1.07M 10-K · filed 2025-03-10 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $11.57M derived: sum of 2 quarters · filed 2023-03-30 | $11.57M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $11.57M 10-Q · filed 2022-11-14 | $11.57M 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |